Literature DB >> 17476362

Is bipolar disorder a mitochondrial disease?

L Trevor Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17476362      PMCID： PMC1863554     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  15 in total

1.  Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis.

Authors:  Kazuya Iwamoto; Miki Bundo; Tadafumi Kato
Journal:  Hum Mol Genet       Date:  2004-11-24       Impact factor: 6.150

2.  Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder.

Authors:  Xiujun Sun; Jun-Feng Wang; Michael Tseng; L Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2006-05       Impact factor: 6.186

Review 3.  Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder.

Authors:  Carlos A Zarate; Jaskaran Singh; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2006-02-17       Impact factor: 13.382

Review 4.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

Review 5.  Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.

Authors:  J K Yao; R D Reddy; D P van Kammen
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 6.  Mitochondrial dysfunction in bipolar disorder.

Authors:  T Kato; N Kato
Journal:  Bipolar Disord       Date:  2000-09       Impact factor: 6.744

7.  Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.

Authors:  J Cui; L Shao; L T Young; J-F Wang
Journal:  Neuroscience       Date:  2006-12-19       Impact factor: 3.590

8.  Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene.

Authors:  Mirjana Tosic; Jurg Ott; Sandra Barral; Pierre Bovet; Patricia Deppen; Fulvia Gheorghita; Marie-Louise Matthey; Josef Parnas; Martin Preisig; Michael Saraga; Alessandra Solida; Sally Timm; August G Wang; Thomas Werge; Michel Cuénod; Kim Quang Do
Journal:  Am J Hum Genet       Date:  2006-07-31       Impact factor: 11.025

9.  Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits.

Authors:  H Puccio; D Simon; M Cossée; P Criqui-Filipe; F Tiziano; J Melki; C Hindelang; R Matyas; P Rustin; M Koenig
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

Review 10.  Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets.

Authors:  Paul J Carlson; Jaskaran B Singh; Carlos A Zarate; Wayne C Drevets; Husseini K Manji
Journal:  NeuroRx       Date:  2006-01
View more
  15 in total

1.  Cocaine use in the past year is associated with altitude of residence.

Authors:  Kristen K Fiedler; Namkug Kim; Douglas G Kondo; Perry F Renshaw
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

2.  N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice.

Authors:  David-Marian Otte; Britta Sommersberg; Alexei Kudin; Catalina Guerrero; Onder Albayram; Michaela D Filiou; Pamela Frisch; Oznur Yilmaz; Eva Drews; Christoph W Turck; Andras Bilkei-Gorzó; Wolfram S Kunz; Heinz Beck; Andreas Zimmer
Journal:  Neuropsychopharmacology       Date:  2011-06-29       Impact factor: 7.853

Review 3.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

4.  Micronutrients versus standard medication management in autism: a naturalistic case-control study.

Authors:  Lewis Mehl-Madrona; Brenda Leung; Carla Kennedy; Sarah Paul; Bonnie J Kaplan
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-04       Impact factor: 2.576

5.  Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula.

Authors:  Julia J Rucklidge; Dermot Gately; Bonnie J Kaplan
Journal:  BMC Psychiatry       Date:  2010-09-28       Impact factor: 3.630

6.  Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania.

Authors:  Steven T Szabo; Rodrigo Machado-Vieira; Peixiong Yuan; Yun Wang; Yanling Wei; Cynthia Falke; Chiara Cirelli; Giulio Tononi; Husseini K Manji; Jing Du
Journal:  Neuropharmacology       Date:  2008-08-22       Impact factor: 5.250

Review 7.  Broad-spectrum micronutrient treatment for attention-deficit/hyperactivity disorder: rationale and evidence to date.

Authors:  Julia J Rucklidge; Bonnie J Kaplan
Journal:  CNS Drugs       Date:  2014-09       Impact factor: 5.749

8.  The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.

Authors:  Jing Du; Thomas K Creson; Long-Jun Wu; Ming Ren; Neil A Gray; Cynthia Falke; Yanling Wei; Yun Wang; Rayah Blumenthal; Rodrigo Machado-Vieira; Peixiong Yuan; Guang Chen; Min Zhuo; Husseini K Manji
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

Review 9.  Bipolar disorder diagnosis: challenges and future directions.

Authors:  Mary L Phillips; David J Kupfer
Journal:  Lancet       Date:  2013-05-11       Impact factor: 79.321

10.  Psychiatric symptoms correlate with metabolic indices in the hippocampus and cingulate in patients with mitochondrial disorders.

Authors:  R E Anglin; P I Rosebush; M D Noseworthy; M Tarnopolsky; M F Mazurek
Journal:  Transl Psychiatry       Date:  2012-11-13       Impact factor: 6.222
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.